SCHEMBL14739170

SCHEMBL14739170

O=C(O)CCc1c(C(=O)O)[nH]c2c(F)c(-c3ccccc3)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 10/20 1.00
FBP1 P09467 6/20 0.56
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14738959 0.91 GPR17 (0.84) GPR17FBP1KDM4EALDH1A1
SCHEMBL14739513 0.82 GPR17 (0.70) GPR17FBP1KDM4EALDH1A1
SCHEMBL14739871 0.82 GPR17 (1.00) GPR17FBP1KDM4EALDH1A1
SCHEMBL14739389 0.81 GPR17 (1.00) GPR17FBP1KDM4EALDH1A1
SCHEMBL14738966 0.81 GPR17 (1.00) GPR17FBP1KDM4EALDH1A1
SCHEMBL14739168 0.73 GPR17 (1.00) GPR17FBP1KDM4EALDH1A1
SCHEMBL14739118 0.72 GPR17 (0.76) GPR17FBP1KDM4EALDH1A1
SCHEMBL9188167 0.72 GPR17 (0.67) GPR17FBP1KDM4EALDH1A1
SCHEMBL29432490 0.71 KDM4E (1.00) GPR17KDM4EALDH1A1
SCHEMBL9188195 0.71 KDM4E (1.00) GPR17KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623593-B1 GPR 17 agonists and screening assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2014-01-07 US claimed
US-20130338374-A1 GPR 17 AGONISTS AND SCREENING ASSAY Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-12-19 US claimed
US-20130158093-A1 GPR 17 Agonists and Screening Assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-06-20 US claimed
US-8404436-B1 Methods of identifying modulators of GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-26 US claimed
US-20130059899-A1 METHODS OF IDENTIFYING MODULATORS OF GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-07 US claimed
US-8623593-B1 GPR 17 agonists and screening assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2014-01-07 US disclosed
US-8623593-B1 GPR 17 agonists and screening assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2014-01-07 US disclosed
US-8623593-B1 GPR 17 agonists and screening assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2014-01-07 US disclosed
US-20130338374-A1 GPR 17 AGONISTS AND SCREENING ASSAY Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-12-19 US disclosed
US-20130158093-A1 GPR 17 Agonists and Screening Assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-06-20 US disclosed
US-20130158093-A1 GPR 17 Agonists and Screening Assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-06-20 US disclosed
US-20130158093-A1 GPR 17 Agonists and Screening Assay Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2013-06-20 US disclosed
US-8404436-B1 Methods of identifying modulators of GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-26 US disclosed
US-8404436-B1 Methods of identifying modulators of GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-26 US disclosed
US-8404436-B1 Methods of identifying modulators of GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-26 US disclosed
US-20130059899-A1 METHODS OF IDENTIFYING MODULATORS OF GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-07 US disclosed
US-20130059899-A1 METHODS OF IDENTIFYING MODULATORS OF GPR17 RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN (DE) 2013-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059899-A1 METHODS OF IDENTIFYING MODULATORS OF GPR17 GPR27, GPR17, GPR65 GPR17 2/4885FBP1 2790/4885KDM4E 3598/4885
US-20130338374-A1 GPR 17 AGONISTS AND SCREENING ASSAY GPR27, GPR17, GPR65 GPR17 2/4885FBP1 3381/4885KDM4E 4167/4885
US-20130158093-A1 GPR 17 Agonists and Screening Assay GPR27, GPR17, GPR65 GPR17 2/4885FBP1 3381/4885KDM4E 4167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.